Medpage Today: Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says

Beware a maculopapular rash years after left ventricular assist device (LVAD) implantation, according to clinicians describing the phenomenon of LVAD vasculitis in a case series.

Three cases of LVAD recipients affected with vasculitis within the past 3 years at University Hospital Cleveland Medical Center -- all cases infectious-related and accompanied by renal failure -- were reported by Raul Angel Garcia, DO, of Saint Luke's Mid America Heart Institute in Kansas City, Missouri, and colleagues.

With their case series in JACC: Case Reports, the authors put a spotlight on the phenomenon of inflammatory vessel disease with systemic dysfunction in an LVAD recipient. Leukocytoclastic vasculitis (LCV) due to Listeria monocytogenes infection in an LVAD patient had been described once before in a 2016 case report from New York City.

Read the full Medpage Today article: Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says

Related Content

Thumbnail
Jul. 5, 2021

Endocrinology Network: DISCOVER Details Gradual Uptake, Need for Improvement in Prescribing of SGLT2 Inhibitors, GLP-1 RAs
Endocrinology Network talked to Dr. Suzanne Arnold about the DISCOVER registry and the take-home message of its findings.
Jun. 28, 2021

Healio: DARE-19: Dapagliflozin well-tolerated for inpatient COVID-19 with, without diabetes
The SGLT2 inhibitor dapagliflozin is well-tolerated in adults hospitalized with COVID-19, regardless of diabetes status, according to new analyses from the DARE-19 trial.
Medscape logo
Jun. 8, 2021

Medscape: Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy
Medscape details the promising findings of the EXPLORER-HCM Phase 3 Trial presented by Dr. John Spertus at the 2021 ACC Scientific Session.